Evidence map›Paper›PMID 38132041›Full record

ArticleHealthcare (Basel, Switzerland)2023

Common Bacterial Infections during the 3-Month Period after SARS-CoV-2 Infection: A Retrospective Cohort Study.

Bar Cohen, Shirley Shapiro Ben David, Daniella Rahamim-Cohen, Afif Nakhleh, Arnon Shahar, Ilan Yehoshua, Avital Bilitzky-Kopit, Joseph Azuri, Miri Mizrahi Reuveni, Limor Adler

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Bar CohenHealth Division, Maccabi Healthcare Services, Tel Aviv 6812509, Israel.
Shirley Shapiro Ben DavidHealth Division, Maccabi Healthcare Services, Tel Aviv 6812509, Israel.
Daniella Rahamim-CohenHealth Division, Maccabi Healthcare Services, Tel Aviv 6812509, Israel.ORCID 0009-0007-9440-5592
Afif NakhlehDiabetes and Endocrinology Clinic, Maccabi Healthcare Services, Haifa 3299001, Israel.ORCID 0000-0003-1206-1516
Arnon ShaharHealth Division, Maccabi Healthcare Services, Tel Aviv 6812509, Israel.
Ilan YehoshuaHealth Division, Maccabi Healthcare Services, Tel Aviv 6812509, Israel.
Avital Bilitzky-KopitHealth Division, Maccabi Healthcare Services, Tel Aviv 6812509, Israel.
Joseph AzuriHealth Division, Maccabi Healthcare Services, Tel Aviv 6812509, Israel.ORCID 0000-0003-1049-9848
Miri Mizrahi ReuveniHealth Division, Maccabi Healthcare Services, Tel Aviv 6812509, Israel.
Limor AdlerHealth Division, Maccabi Healthcare Services, Tel Aviv 6812509, Israel.ORCID 0000-0002-9335-6596
Tel Aviv University · ILBen-Gurion University of the Negev · ILBar-Ilan University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCorrelations between SARS-CoV-2 and bacterial infections have mainly been studied in hospitals, and these studies have shown that such interactions may be lethal for many. In the context of community flora, less is known of the trends and consequences of viral infections relative to subsequent bacterial infections. PURPOSE: This study aims to explore the prevalence and characteristics of bacterial infections in the three months following SARS-CoV-2 infections, in a community, real-world setting.

methodsIn this retrospective cohort study, we compared patients who completed a polymerase chain reaction (PCR) test or an antigen test for SARS-CoV-2 during January 2022, the peak of the Omicron wave, and examined bacterial infections following the test. We searched these cases for diagnoses of the following four bacterial infections for three months following the test: Group A Streptococcus (GAS) pharyngitis, pneumonia, cellulitis, and urinary tract infections (UTI).

resultsDuring January 2022, 267,931 patients tested positive and 261,909 tested negative for SARS-CoV-2. Test-positive compared to test-negative patients were significantly younger (42.5 years old vs. 48.5 years old,

conclusionsA history of SARS-CoV-2 infection in the past three months increased susceptibility to respiratory tract bacterial infections and the prevalence of UTI.

Indexed as

bacterial infectionsCOVID-19group A streptococcus pharyngitispneumoniaSARS-CoV-2urinary tract infections

Identifiers

PMID38132041
PMCPMC10742933
OpenAlexW4389624134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.